Phytohealth Corp Total Assets
Phytohealth Corp total assets. Based on the latest financial reports, Phytohealth Corp (4108) holds total assets worth NT$2.41 Billion TWD (≈ $75.98 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Phytohealth Corp market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Phytohealth Corp (2002–2025)
Total assets of Phytohealth Corp from 2002 to 2025. This chart illustrates how Phytohealth Corp's total assets have evolved over time, based on quarterly financial data. See Phytohealth Corp share price for real-time trading data and today's change.
Phytohealth Corp - Asset Composition Analysis
Phytohealth Corp Total Assets Breakdown (December 2025)
Phytohealth Corp total assets breakdown as of December 2025. Phytohealth Corp's total assets of NT$2.41 Billion consist of 53.7% current assets and 46.3% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 3.7% |
| Accounts Receivable | NT$36.36 Million | 1.6% |
| Inventory | NT$126.08 Million | 5.4% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$28.83 Million | 1.2% |
| Goodwill | NT$31.18 Million | 1.3% |
Asset Composition Trend (2002–2025)
This chart illustrates how Phytohealth Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of Phytohealth Corp to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Phytohealth Corp's current assets represent 53.7% of total assets in 2025, an increase from 0.0% in 2002.
- Cash Position: Cash and equivalents constituted 3.7% of total assets in 2025, down from 27.3% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2002.
- Asset Diversification: The largest asset category is inventory at 5.4% of total assets.
Phytohealth Corp Competitors by Total Assets
Key competitors of Phytohealth Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Galderma Group N
SW:GALD
|
Switzerland | CHF12.88 Billion |
|
Enzymatica publ AB
ST:ENZY
|
Sweden | Skr149.24 Million |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥13.98 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Walvax BioTech
SHE:300142
|
China | CN¥10.50 Billion |
Phytohealth Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 29.17 | 37.31 | 25.77 |
| Quick Ratio | 26.44 | 33.70 | 23.33 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$1.14 Billion | NT$1.46 Billion | NT$1.59 Billion |
Phytohealth Corp - Advanced Valuation Insights
This section examines the relationship between Phytohealth Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.20 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | -3.5% |
| Total Assets | NT$2.35 Billion |
| Market Capitalization | $70.40 Million USD |
Valuation Analysis
Below Book Valuation: The market values Phytohealth Corp's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Phytohealth Corp's assets decreased by 3.5% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Phytohealth Corp (2002–2025)
The table below shows the annual total assets of Phytohealth Corp from 2002 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | NT$2.35 Billion ≈ $74.13 Million |
-3.55% |
| 2024-12-31 | NT$2.44 Billion ≈ $76.86 Million |
+3.79% |
| 2023-12-31 | NT$2.35 Billion ≈ $74.05 Million |
-0.60% |
| 2022-12-31 | NT$2.36 Billion ≈ $74.50 Million |
-4.27% |
| 2021-12-31 | NT$2.47 Billion ≈ $77.82 Million |
+36.50% |
| 2020-12-31 | NT$1.81 Billion ≈ $57.01 Million |
-3.84% |
| 2019-12-31 | NT$1.88 Billion ≈ $59.29 Million |
-9.01% |
| 2018-12-31 | NT$2.07 Billion ≈ $65.16 Million |
-5.65% |
| 2017-12-31 | NT$2.19 Billion ≈ $69.07 Million |
-9.60% |
| 2016-12-31 | NT$2.42 Billion ≈ $76.40 Million |
+3.64% |
| 2015-12-31 | NT$2.34 Billion ≈ $73.72 Million |
-6.00% |
| 2014-12-31 | NT$2.49 Billion ≈ $78.42 Million |
-11.85% |
| 2013-12-31 | NT$2.82 Billion ≈ $88.97 Million |
-2.06% |
| 2012-12-31 | NT$2.88 Billion ≈ $90.84 Million |
+74.70% |
| 2011-12-31 | NT$1.65 Billion ≈ $52.00 Million |
-13.45% |
| 2010-12-31 | NT$1.91 Billion ≈ $60.08 Million |
-9.79% |
| 2009-12-31 | NT$2.11 Billion ≈ $66.60 Million |
+96.20% |
| 2008-12-31 | NT$1.08 Billion ≈ $33.94 Million |
-30.74% |
| 2007-12-31 | NT$1.56 Billion ≈ $49.01 Million |
+15.04% |
| 2006-12-31 | NT$1.35 Billion ≈ $42.60 Million |
+11.66% |
| 2005-12-31 | NT$1.21 Billion ≈ $38.15 Million |
+296.80% |
| 2004-12-31 | NT$305.18 Million ≈ $9.61 Million |
-11.31% |
| 2003-12-31 | NT$344.09 Million ≈ $10.84 Million |
+120.54% |
| 2002-12-31 | NT$156.02 Million ≈ $4.92 Million |
-- |
About Phytohealth Corp
PhytoHealth Corporation researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and other related products in Taiwan. It operates in three segments: Medicines and Health Food, Medical Diagnosis, and Precision Medical Equipment and Instruments. The Medicines and Health Food segment manufactures and sells Chinese medicine materials and new drugs. … Read more